What the program changed
FDA approved changes to the isotretinoin safety program in February and moved the planned implementation date to November 15. The iPLEDGE program now lists the revisions as effective on that date.12
To get authorization for patients who cannot get pregnant, the pharmacist enters the prescriber’s National Provider Identifier. The program no longer assigns a dispense-by date for those patients. Pharmacies must reverse the authorization in iPLEDGE if the prescription returns to stock. Each fill still requires a new prescription and authorization, a Medication Guide, and a supply of no more than 30 days. The pharmacy’s authorized representative must document training at enrollment and annually thereafter.13
The seven-day pickup window continues for patients who can get pregnant. If a patient misses that window before starting treatment, they can repeat the required confirmatory pregnancy test in a medical setting without the previous waiting period.123
Checking the pharmacy workflow
Chad’s analysis. Build the prescriber identifier check into the authorization workflow. Keep patient category visible during pickup review so staff can distinguish a seven-day pickup window from a 30-day supply limit. Put the authorization reversal in the same checklist staff use to return the unused prescription to stock.